Fingerpaint
Mark Willmann has a diverse work experience spanning over 25 years. Mark is currently serving as the President of Marketing Services at Fingerpaint since December 2021. Prior to this, they were the President of McCann Health New Jersey from December 2015 to August 2018. Mark also held the position of Managing Director at McCann Health New Jersey from January 2013 to December 2015. Before joining McCann Health, Mark worked as the VP and Director of Scientific Integration at Echo TL from 2004 to 2008. Mark started their career at Population Council at Rockefeller University as a Research Associate in 1995. Overall, they have a strong background in marketing services and scientific integration.
Mark Willmann attended Lehigh University from 1991 to 1995, where they obtained a Bachelor of Science degree in Molecular Biology.
This person is not in any teams
This person is not in any offices
Fingerpaint
3 followers
Fingerpaint, built on a foundation of empathy, at its core is committed to creating and executing meaningful brand experiences that are never paint by number for healthcare providers, care partners, and patients. In 2020, Fingerpaint acquired 1798, a market access and commercialization firm located in La Jolla, Calif., adding to its portfolio of services in support of biopharma customers. The agency also launched Photo 51, a gene therapy consultancy. Fingerpaint was named 2019 Agency of the Year by Med Ad News, and in 2018, it won the Heart Award from Med Ad News for its commitment to philanthropy and social causes. Additionally, it has been on Inc. Magazine’s list of the 5,000 Fastest-Growing Companies for the past eight years.